Harmony Biosciences Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.60 | $0.60 | $0.60 |
| Q2 2024 | 1 | -$0.00 | -$0.00 | -$0.00 |
| Q3 2024 | 1 | $0.66 | $0.67 | $0.66 |
| Q4 2024 | 4 | $0.51 | $0.86 | $0.68 |
| Q1 2025 | 3 | $0.41 | $0.75 | $0.64 |
| Q2 2025 | 2 | $0.68 | $0.74 | $0.71 |
| Q3 2025 | 2 | $0.73 | $0.78 | $0.76 |
| Q4 2025 | 2 | $0.77 | $0.83 | $0.80 |
| Q1 2026 | 1 | $0.85 | $0.92 | $0.89 |
| Q2 2026 | 1 | $1.01 | $1.08 | $1.04 |
| Q3 2026 | 1 | $1.10 | $1.18 | $1.14 |
| Q4 2026 | 1 | $1.16 | $1.25 | $1.20 |
Harmony Biosciences Holdings, Inc. Earnings Date And Information
Harmony Biosciences Holdings, Inc. last posted its earnings results on Tuesday, October 29th, 2024. The company reported $0.79 earnings per share for the quarter, topping analysts' consensus estimates of $0.67 by $0.12. The company had revenue of 186.04 M for the quarter and had revenue of 582.02 M for the year. Harmony Biosciences Holdings, Inc. has generated $2 earnings per share over the last year ($2.13 diluted earnings per share) and currently has a price-to-earnings ratio of 15.53. Harmony Biosciences Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Harmony Biosciences Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q3 2024 | $0.67 | $0.81 | 0.14 | $184.07 M | $186.04 M |
| 08/06/2024 | Q2 2024 | -$0.06 | $0.20 | 0.26 | $172.53 M | $172.81 M |
| 04/30/2024 | Q1 2024 | $0.60 | $0.68 | 0.08 | $154.62 M | |
| 02/28/2024 | Q4 2023 | $0.46 | $168.41 M | |||
| 10/31/2023 | Q3 2023 | $0.65 | $0.64 | -0.01 | $147.83 M | $160.27 M |
| 08/01/2023 | Q2 2023 | $0.63 | $0.57 | -0.06 | $142.01 M | $134.22 M |
| 05/02/2023 | Q1 2023 | $0.44 | $0.49 | 0.05 | $119.13 M | |
| 02/21/2023 | Q4 2022 | $0.58 | $0.82 | 0.24 | $128.31 M | |
| 11/01/2022 | Q3 2022 | $0.10 | $1.48 | 1.38 | $113.59 M | $117.21 M |
| 08/02/2022 | Q2 2022 | $0.40 | $0.40 | 0 | $100.73 M | $107.03 M |
| 05/03/2022 | Q1 2022 | $0.25 | $0.36 | 0.11 | $85.31 M | |
| 02/28/2022 | Q4 2021 | $0.32 | $0.39 | 0.07 | $91.21 M | |
| 11/09/2021 | Q3 2021 | $0.27 | -$0.17 | -0.44 | $79.90 M | $80.73 M |
| 08/10/2021 | Q2 2021 | $0.19 | $0.25 | 0.06 | $68.83 M | $73.82 M |
| 05/11/2021 | Q1 2021 | $0.02 | $0.13 | 0.11 | $59.67 M | |
| 03/25/2021 | Q4 2020 | -$0.00 | $56.29 M | |||
| 11/12/2020 | Q3 2020 | -$0.05 | -$0.14 | -0.09 | $40.00 M | $45.61 M |
| 06/29/2020 | Q2 2020 | -$0.00 | $38.01 M | |||
| 03/30/2020 | Q1 2020 | -$0.70 | $19.84 M | |||
| 12/30/2019 | Q4 2019 | -$0.66 | $6.00 M |
Harmony Biosciences Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Harmony Biosciences Holdings, Inc.'s earnings date?
Harmony Biosciences Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
Did Harmony Biosciences Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Harmony Biosciences Holdings, Inc. (:HRMY) reported $0.79 earnings per share (EPS) to beat the analysts' consensus estimate of $0.67 by $0.12.
-
How can I listen to Harmony Biosciences Holdings, Inc.'s earnings conference call?
The conference call for Harmony Biosciences Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Harmony Biosciences Holdings, Inc.'s conference call transcript?
The conference call transcript for Harmony Biosciences Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Harmony Biosciences Holdings, Inc. generate each year?
Harmony Biosciences Holdings, Inc. (:HRMY) has a recorded annual revenue of $582.02 M.
-
How much profit does Harmony Biosciences Holdings, Inc. generate each year?
Harmony Biosciences Holdings, Inc. (:HRMY) has a recorded net income of $582.02 M. Harmony Biosciences Holdings, Inc. has generated $2.17 earnings per share over the last four quarters.
-
What is Harmony Biosciences Holdings, Inc.'s price-to-earnings ratio?
Harmony Biosciences Holdings, Inc. (:HRMY) has a price-to-earnings ratio of 15.53 and price/earnings-to-growth ratio is 1.81.
